Please Select Your Country

Engineered For Excellence

Together, Boston Scientific and BTG seek to be a stronger clinical partner through expansion of our vascular treatment options

What's New

BOSTON SCIENTIFIC CLOSES ACQUISITION OF BTG PLC.

Read more

Venous Leg Ulcer Registry Shows Promising Results for Varithena® Use in Wound Healing

Read more

EKOS™ Control Unit 4.0 simplifies treatment of blood clots

Read more

EXPLORE BTG VASCULAR

Varithena®

From tortuosity to GSV, Varithena® can. The versatile, can-do vein treatment your clinic needs.
Click here to learn more
EKOS™

Did you know the EKOS™ System is the first device cleared by the FDA for the treatment of Pulmonary Embolism? The EKOS™ system continues to break new ground in PE, DVT, PAO treatment.
Click here to learn more
BTG Crossing Devices

Navigate challenging peripheral and coronary anatomies.

Using BTG Crossing Devices together can give physicians the confidence that results from greater control over intraluminal-occlusion.

Click here to learn more
BTG Sentry

Protection when you need it. Patency when you don’t. The BTG Sentry Bioconvertible IVC Filter is designed to provide immediate protection¹ against Pulmonary Embolism (PE) in patients at transient risk of PE.
Click here to learn more
¹ Michael D. Dake, M.D. et al, Presented at VIVA 2017, Las Vegas, NV, September 2017.